[Lipid metabolism disorders caused by saluretics].
D001581:Benzothiadiazines; D002784:Cholesterol / Q000097:blood; D002788:Cholesterol Esters / Q000097:blood; D004232:Diuretics / Q000009:adverse effects*; D004338:Drug Combinations; D005951:Glucose Tolerance Test; D006029:Glycosuria; D050356:Lipid Metabolism; D008055:Lipids / Q000097:blood; D010743:Phospholipids / Q000097:blood; D049993:Sodium Chloride Symporter Inhibitors / Q000009:adverse effects*; D014223:Triamterene / Q000009:adverse effects; D014280:Triglycerides / Q000097:blood; D014527:Uric Acid / Q000097:blood; D014988:Xipamide / Q000009:adverse effects*
D001581:Benzothiadiazines; D002788:Cholesterol Esters; D004232:Diuretics; D004338:Drug Combinations; D008055:Lipids; D010743:Phospholipids; D049993:Sodium Chloride Symporter Inhibitors; D014280:Triglycerides; D014527:Uric Acid; D014988:Xipamide; D002784:Cholesterol; D014223:Triamterene
Untersuchungen zur Fettstoffwechselstörung durch Saluretika.